Yes, GLP-1 medications can generally be used in patients with high blood pressure, but clinical oversight and careful monitoring are essential
Some Injuries Remain in Limbo Many people who have suffered injuries from GLP-1 drugs have joined a multidistrict lawsuit (MDL) called MDL 3094: In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation
oral research formulations of semaglutide are not standard in the research peptide market and require a substantially more complex preparation than subcutaneous reconstitution
20, 2025) The Partnership for Safe Medicines today released a new report that found suspicious, unauthorized, and illegal ingredients for popular diabetes and obesity injectables (commonly known as weight loss drugs) are flooding into the U.S
Hepatic inflammatory responses in liver fibrosis
Abstract GLP-1 receptor agonists, including semaglutide, are increasingly used to treat obesityand to a lesser extent, type 2 diabetesin children and adolescents